Sun Pharma Inds. - Quaterly Results
Date: 03-08-2023
Net sales declined -9.46% to Rs. 44660.70 million from Rs. 49328.80 millions.Net Profit of the company move down -62.38% to Rs. 3806.40 millions from Rs. 10118.00 millions in the same quarter last year.The company reported a degrowth in operating Profit to 11123.00 millions from 14986.50 millions.
| | Quarter ended | Year to Date | Year ended |
| | 202306 | 202206 | % Var | 202306 | 202206 | % Var | 202303 | 202203 | % Var |
| Sales | 44660.70 | 49328.80 | -9.46 | 44660.70 | 49328.80 | -9.46 | 208121.40 | 155859.80 | 33.53 |
| Other Income | 1635.40 | 1762.10 | -7.19 | 1635.40 | 1762.10 | -7.19 | 3292.90 | 11968.80 | -72.49 |
| PBIDT | 11123.00 | 14986.50 | -25.78 | 11123.00 | 14986.50 | -25.78 | 67518.90 | 38654.40 | 74.67 |
| Interest | 1579.40 | 870.70 | 81.39 | 1579.40 | 870.70 | 81.39 | 4721.80 | 3881.00 | 21.66 |
| PBDT | 8051.50 | 14115.80 | -42.96 | 8051.50 | 14115.80 | -42.96 | 33419.20 | 16568.10 | 101.71 |
| Depreciation | 4152.70 | 3745.00 | 10.89 | 4152.70 | 3745.00 | 10.89 | 16008.70 | 13499.50 | 18.59 |
| PBT | 3898.80 | 10370.80 | -62.41 | 3898.80 | 10370.80 | -62.41 | 17410.50 | 3068.60 | 467.38 |
| TAX | 92.40 | 252.80 | -63.45 | 92.40 | 252.80 | -63.45 | 503.30 | 4068.50 | -87.63 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 3806.40 | 10118.00 | -62.38 | 3806.40 | 10118.00 | -62.38 | 16907.20 | -999.90 | -1790.89 |
| Equity | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 |
| PBIDTM(%) | 24.91 | 30.38 | -18.02 | 24.91 | 30.38 | -18.02 | 32.44 | 24.80 | 30.81 |